Ultragenyx Pharmaceutical (RARE) Gross Margin Growth (1y) (2019 - 2026)
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Gross Margin Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 210.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1,966.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 228.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -475.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1,034.00 |
| 10 | Ultragenyx Pharmaceutical | 1.56 Bn | 1.27 Bn | 180.00 Mn | -212.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -212.00 |
| Mar 31, 2026 | -120.00 |
| Dec 31, 2025 | -373.00 |
| Sep 30, 2025 | -243.00 |
| Jun 30, 2025 | 70.00 |
| Mar 31, 2025 | -475.00 |
| Dec 31, 2024 | -111.00 |
| Sep 30, 2024 | -386.00 |
| Jun 30, 2024 | -532.00 |
| Mar 31, 2024 | -391.00 |
| Dec 31, 2023 | -417.00 |
| Sep 30, 2023 | -169.00 |
| Jun 30, 2023 | 10.00 |
| Mar 31, 2023 | -457.00 |
| Dec 31, 2022 | -94.00 |
| Sep 30, 2022 | -440.00 |
| Jun 30, 2022 | -565.00 |
| Mar 31, 2022 | -241.00 |
| Dec 31, 2021 | 178.00 |
| Sep 30, 2021 | -223.00 |